Therapeutical Aspects and Outcome of HIV/HCV Coinfected Patients Treated with Pegylated Interferon plus Ribavirin in an Italian Cohort

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection

Michael Fried, Mitchell L. Shiffman, K. Rajender Reddy et al. · New England Journal of Medicine · 2002 · 6.4K citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected Patients

Francesca J. Torriani, M. Rodríguez‐Torres, Jürgen K. Rockstroh et al. · New England Journal of Medicine · 2004 · 1.2K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Increasing Mortality Due to End-Stage Liver Disease in Patients with Human Immunodeficiency Virus Infection

Ioana Bica, Barbara McGovern, Ravi Dhar et al. · Clinical Infectious Diseases · 2001 · 976 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +15

Peginterferon Alfa-2a plus Ribavirin versus Interferon Alfa-2a plus Ribavirin for Chronic Hepatitis C in HIV-Coinfected Persons

Raymond T. Chung, Janet Andersen, Paul A. Volberding et al. · New England Journal of Medicine · 2004 · 873 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Pegylated Interferon Alfa-2b vs Standard Interferon Alfa-2b, Plus Ribavirin, for Chronic Hepatitis C in HIV-Infected Patients<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

Fabrice Carrat · JAMA · 2004 · 797 citations

Medicine, Infectious Diseases, Pharmacology +17